Ovarian carcinosarcoma of heterologous type occurring in an endometriotic cyst with 3-year recurrence-free survival: a case report and literature review.

OA: closed

Abstract

A 41-year-old premenopausal woman presented to our hospital with lower abdominal distention and epigastralgia. An ovarian endometriotic cyst was noted when she was 30 years, and was only followed up until she was 36 years. Suspecting rupture of an ovarian tumor, left adnexectomy was performed. The left ovarian tumor was diagnosed as an ovarian carcinosarcoma of the heterologous type occurring in the endometriotic cyst. The carcinosarcoma was composed of an admixture of high-grade carcinomatous and sarcomatous components, including rhabdomyosarcoma. Thereafter, secondary surgery was concluded, which confirmed the tumor stage to be pT1c3. She postoperatively received 6 cycles of docetaxel/carboplatin as adjuvant chemotherapy and achieved recurrence-free survival for 40 months. Among ovarian carcinosarcomas, cases occurring in endometriotic cysts are particularly rare and may have a relatively good prognosis, because tumor cells, especially sarcoma components, tend to be confined to the ovaries. Pathological estimation of the origin of carcinosarcoma is important, because it appears to correlate with prognosis.
Full text 6,141 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

A 41-year-old premenopausal woman presented to our hospital with lower abdominal distention and epigastralgia. An ovarian endometriotic cyst was noted when she was 30 years, and was only followed up until she was 36 years. Suspecting rupture of an ovarian tumor, left adnexectomy was performed. The left ovarian tumor was diagnosed as an ovarian carcinosarcoma of the heterologous type occurring in the endometriotic cyst. The carcinosarcoma was composed of an admixture of high-grade carcinomatous and sarcomatous components, including rhabdomyosarcoma. Thereafter, secondary surgery was concluded, which confirmed the tumor stage to be pT1c3. She postoperatively received 6 cycles of docetaxel/carboplatin as adjuvant chemotherapy and achieved recurrence-free survival for 40 months. Among ovarian carcinosarcomas, cases occurring in endometriotic cysts are particularly rare and may have a relatively good prognosis, because tumor cells, especially sarcoma components, tend to be confined to the ovaries. Pathological estimation of the origin of carcinosarcoma is important, because it appears to correlate with prognosis. Similar content being viewed by others Availability of data and materials The data that support the findings of this case report are available from the corresponding author, upon reasonable request.

References

Pang A, Carbini M, Moreira AL, Maki RG (2018) Carcinosarcomas and related cancers: tumors caught in the act of epithelial-mesenchymal transition. J Clin Oncol 36:210–216 Raza MA, Mazzara PF (2011) Sarcomatoid carcinoma of esophagus. Arch Pathol Lab Med 135:945–948 Usui G, Hashimoto H, Kusakabe M et al (2019) Intrahepatic carcinosarcoma with cholangiocarcinoma elements and prominent bile duct spread. Int J Surg Pathol 27:900–906 Wada H, Enomoto T, Fujita M et al (1997) Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res 57:5379–5385 Cherniack AD, Shen H, Walter V et al (2017) Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell 31:411–423 Brown E, Stewart M, Rye T et al (2004) Carcinosarcoma of the ovary: 19 years of prospective data from a single center. Cancer 100:2148–2153 Hollis RL, Croy I, Churchman M et al (2022) Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma. Br J Cancer 127:1034–1042 Athavale R, Thomakos N, Godfrey K et al (2007) The effect of epithelial and stromal tumor components on FIGO stages III and IV ovarian carcinosarcomas treated with primary surgery and chemotherapy. Int J Gynecol Cancer 17:1025–1030 Bicher A, Levenback C, Silva EG et al (1995) Ovarian malignant mixed müllerian tumors treated with platinum-based chemotherapy. Obstet Gynecol 85:735–739 Asano M, Hasegawa K, Tsukada K et al (2014) A case and literature review of ovarian carcinosarcoma with long-term survival after repeated recurrences. Gan To Kagaku Ryoho 41:1031–1036 Jin Z, Ogata S, Tamura G et al (2003) Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis. Int J Gynecol Pathol 22:368–373 Lim D, Murali R, Murray MP et al (2016) Morphological and immunohistochemical reevaluation of tumors initially diagnosed as ovarian endometrioid carcinoma with emphasis on high-grade tumors. Am J Surg Pathol 40:302–312 Cooper P (1978) Mixed mesodermal tumor and clear cell carcinoma arising in ovarian endometriosis. Cancer 42:2827–2831 Marchevsky AM, Kaneko M (1978) Bilateral ovarian endometriosis associated with carcinosarcoma of the right ovary and endometrioid carcinoma of the left ovary. Am J Clin Pathol 70:709–712 Macfarlane KT, Pritchard JE (1954) Two cases of Müllerian carcinosarcoma. Am J Obstet Gynecol 68:652–658 Marcella LC, Cromer JK (1959) Mixed mesodermal tumors; a report of 11 cases. Am J Obstet Gynecol 77:275–285 Tsolakian IG, Crim A, Lynn A et al (2021) Endometriosis-associated colorectal carcinosarcoma: a case report and review of the literature. Gynecol Oncol Rep 35:100696 Powell MA, Filiaci VL, Hensley ML et al (2019) A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial. J Clin Oncol 37:5500 Chandran EA, Kennedy I (2018) Significant tumor response to the poly (ADP-ribose) Polymerase inhibitor olaparib in heavily pretreated patient with ovarian carcinosarcoma harboring a germline RAD51D mutation. JCO Precis Oncol 2:1–4

Acknowledgements

We would like to thank the clinical technologists of NTT Medical Center Tokyo for their assistance with the experiments, and Editage (www.editage.jp) for English language editing. Funding The authors received no financial support for this report. Author information Authors and Affiliations Contributions N.S., M.D., and Ma.S. clinically treated this patient, which included surgery; Mi.S., H.H., Y.S., and T.M. were responsible for the pathological diagnosis; and Mi.S. and H.H. prepared the manuscript. All authors have read and approved this manuscript. Corresponding author Ethics declarations Conflict of interest The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Ethical approval An approval is not required for case report in our institutional ethical committee. Informed consent Informed consent was obtained from the patient. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. About this article Cite this article Sumino, M., Hashimoto, H., Sato, N. et al. Ovarian carcinosarcoma of heterologous type occurring in an endometriotic cyst with 3-year recurrence-free survival: a case report and literature review. Int Canc Conf J 14, 21–26 (2025). https://doi.org/10.1007/s13691-024-00728-9 Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s13691-024-00728-9

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-07-21T06:11:07.228698+00:00